We have published a series of reports dedicated to assisting companies in business development and deal making in the pharmaceutical & healthcare sectors.
Published reports include:
- Deal Making Spotlight on Pfizer - Deal Making Spotlight on sanofi-aventis - Deal Making Spotlight on GlaxoSmithKline - Deal Making Spotlight on Johnson & Johnson - Deal Making Spotlight on Novartis
This report 'Deal Making Spotlight on GlaxoSmithKline' details the deal making activities of GlaxoSmithKline, from 2000 up to and including the whole of 2005. If you are looking to partner with big pharma, this report is crucial to your deal making strategy.
Each report is:
Insightful - Presents and discusses the deal making activities of the company and its subsidiaries over a 5-year period. Key trends are identified, providing you with full information about your potential partner.
Analytical - Analysis of deal making trends identifies: which phase each company deals at; how much each company pays for deals; what type of deals are made; what therapy areas are represented. This ensures you have the full information you need to plan the next step towards your deal.
Comprehensive - The deal making profile covers all deals made by the company and its subsidiaries between 2000 and 2005. Commentary is supported by full lists of deals made as well as articles that provide in-depth analysis of key deals made by the company in question
